Targeting human respiratory syncytial virus transcription anti-termination factor m2-1 to inhibit in vivo viral replication

HIGHLIGHTS

• who: B. Bailly from the InstitutGriffith University, Gold Coast Campus, Gold Coast, QLD, Australia have published the research: Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication, in the Journal: Scientific Reports Scientific Reports
• how: The authors hypothesized that the anti-hRSV activity of CPM may be mediated by Shhp and the Smo receptor. The data are consistent with previous studies which demonstrated that this residue is critical for RdRp activity.

SUMMARY

| 6:25806 | By screening libraries of known bioactive compounds, the authors . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.